Fulgent Genetics Inc (FLGT)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 180,235 183,104 182,975 183,729 186,715 194,198 208,915 221,699 252,067 259,484 243,390 219,183 215,533 205,171 187,966 159,825 89,807 41,669 19,293 15,196
Payables US$ in thousands — — — — — — — — — — — — — — — — — — — —
Payables turnover — — — — — — — — — — — — — — — — — — — —

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $180,235K ÷ $—K
= —

The payables turnover ratio for Fulgent Genetics Inc has been indicated as "—", or not available, for all the financial periods provided from March 31, 2020, to December 31, 2024. The payables turnover ratio is a financial metric that provides insights into how efficiently a company is managing its accounts payable by comparing it to its cost of goods sold.

The absence of data for the payables turnover ratio suggests that specific information, related to accounts payable and cost of goods sold, required to calculate this ratio may not have been disclosed in the financial statements or is not publicly available. Without this key data, it is challenging to evaluate the company's performance in managing its accounts payable and assessing its liquidity and efficiency in paying off its debts to suppliers.

In the absence of the payables turnover ratio, other financial ratios and analysis tools would need to be examined to gain a comprehensive understanding of Fulgent Genetics Inc's financial performance and liquidity management. It is recommended that investors and stakeholders consider obtaining more detailed financial information or consulting with the company directly for a deeper insight into its payables management strategy.